Dahlöf, BjÖRn: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Correlates of pulse pressure reduction during antihypertensive treatment (losartan or atenolol) in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study)

Eva Gerdts, Vasilios Papademetriou, Vittorio Palmieri, Kurt Boman, Hans Björnstad, Kristian Wachtell, Thomas D Giles, Björn Dahlöf, Richard B Devereux

Journal:

The American Journal of Cardiology

Year:

2002

Language:

english

File:

PDF, 65 KB

english, 2002

52

Relation of left ventricular geometry and function to aortic root dilatation in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study)

Jonathan N Bella, Kristian Wachtell, Kurt Boman, Vittorio Palmieri, Vasilios Papademetriou, Eva Gerdts, Tapio Aalto, Michael H Olsen, Mona Olofsson, Björn Dahlöf, Mary J Roman, Richard B Devereux

Journal:

The American Journal of Cardiology

Year:

2002

Language:

english

File:

PDF, 71 KB

english, 2002

53

Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial)

Richard B. Devereux, Björn Dahlöf, Daniel Levy, Marc A. Pfeffer

Journal:

The American Journal of Cardiology

Year:

1996

Language:

english

File:

PDF, 668 KB

english, 1996

54

Relations of diastolic left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy (the PRESERVE study)

Vittorio Palmieri, Jonathan N. Bella, Vincent DeQuattro, Mary J. Roman, Rebecca T. Hahn, Bjorn Dahlof, Norman Sharpe, Chu-Pak Lau, Wan-Chun Chen, Esther Paran, Giovanni de Simone, Richard B. Devereux

Journal:

The American Journal of Cardiology

Year:

1999

Language:

english

File:

PDF, 76 KB

english, 1999

55

Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study)

Kristian Wachtell, Gunnar Smith, Eva Gerdts, Björn Dahlöf, Markku S Nieminen, Vasilios Papademetriou, Jonathan N Bella, Hans Ibsen, Jens Rokkedal, Richard B Devereux

Journal:

The American Journal of Cardiology

Year:

2000

Language:

english

File:

PDF, 86 KB

english, 2000

56

Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke

Peter M Rothwell, Sally C Howard, Eamon Dolan, Eoin O'Brien, Joanna E Dobson, Bjorn Dahlöf, Neil R Poulter, Peter S Sever

Journal:

The Lancet Neurology

Year:

2010

Language:

english

File:

PDF, 372 KB

english, 2010

57

Ketanserin in Hypertension : Early Clinical Evaluation and Dose Finding Study of a New 5-HT2 Receptor Antagonist

LENNART ANDRÉN, ANDERS SVENSSON, BJÖRN DAHLÖF, ROBERT EGGERTSEN, LENNART HANSSON

Journal:

Journal of Internal Medicine

Year:

1983

Language:

english

File:

PDF, 429 KB

english, 1983

58

PHARMACOLOGICAL PROPERTIES OF BETA-ADRENOCEPTOR BLOCKERS IN RELATION TO THEIR ANTIHYPERTENSIVE EFFECT

Journal:

Journal of Internal Medicine

Year:

1985

Language:

english

File:

PDF, 106 KB

english, 1985

59

The Diabetes Subgroup Baseline Characteristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) Trial

George Bakris, Allen Hester, Michael Weber, Bjorn Dahlof, Bert Pitt, Eric Velasquez, Linda Staikos-Byrne, Victor Shi, Ken Jamerson, on behalf of the ACCOMPLISH Investigators

Journal:

Journal of the CardioMetabolic Syndrome

Year:

2008

Language:

english

File:

PDF, 236 KB

english, 2008

60

Single-Pill Combination of Telmisartan/Amlodipine in Patients With Severe Hypertension: Results From the TEAMSTA Severe HTN Study

Joel M. Neutel, Giusepe Mancia, Henry R. Black, Bjorn Dahlöf, Holly Defeo, Ludwin Ley, Richard Vinisko, on behalf of the TEAMSTA Severe HTN Study Investigators

Journal:

Journal of Clinical Hypertension

Year:

2012

Language:

english

File:

PDF, 417 KB

english, 2012

61

Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients

Jamerson, Kenneth, Weber, Michael A., Bakris, George L., Dahlöf, Björn, Pitt, Bertram, Shi, Victor, Hester, Allen, Gupte, Jitendra, Gatlin, Marjorie, Velazquez, Eric J.

Journal:

Boston Medical and Surgical Journal

Year:

2008

Language:

english

File:

PDF, 537 KB

english, 2008

62

The role of antihypertensive pharmacologic treatment in countering adverse pathophysiological profiles: Influence on small arteries

Journal:

American Heart Journal

Year:

1987

Language:

english

File:

PDF, 982 KB

english, 1987

63

Long-term experience with the combination of pindolol and isradipine in essential hypertension

Björn Dahlöf, Lennart Andrén, Robert Eggertsen, Sverker Jern, Anders Svensson, Lennart Hansson

Journal:

The American Journal of Medicine

Year:

1988

Language:

english

File:

PDF, 376 KB

english, 1988

64

Hemodynamic response, safety, and efficacy of isradipine in the treatment of essential hypertension

Journal:

The American Journal of Medicine

Year:

1989

Language:

english

File:

PDF, 1.06 MB

english, 1989

65

Additive effect of isradipine in combination with captopril in hypertensive patients

Robert Eggertsen, Anders Svensson, Björn Dahlöf, Lennart Hansson

Journal:

The American Journal of Medicine

Year:

1989

Language:

english

File:

PDF, 313 KB

english, 1989

66

Improved blood pressure control with isradipine in hypertensive patients treated with pindolol

Göran Frithz, Brage åström, Björn Dahlöf, Lennart Hansson, Claes Tollin, Pertti Himanen, Carl-David Sundstedt

Journal:

The American Journal of Medicine

Year:

1989

Language:

english

File:

PDF, 439 KB

english, 1989

67

Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension

Bjorn Dahlöf, Susan E. Keller, Lukas Makris, Allan I. Goldberg, Charles S. Sweet, Nicholas Y. Lim

Journal:

American Journal of Hypertension

Year:

1995

Language:

english

File:

PDF, 589 KB

english, 1995

68

Negative feelings (discontent) predict progress of intima-media thickness of the common carotid artery in treated hypertensive men at high cardiovascular risk

Stefan Agewall, John Wikstrand, Carl Dahlöf, Björn Fagerberg

Journal:

American Journal of Hypertension

Year:

1996

Language:

english

File:

PDF, 685 KB

english, 1996

69

Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study

Kristian Wachtell, Vasilios Papademetriou, Gunnar Smith, Eva Gerdts, Björn Dahlöf, Erik Engblom, Gerard P. Aurigemma, Jonathan N. Bella, Hans Ibsen, Jens Rokkedal, Richard B. Devereux

Journal:

American Heart Journal

Year:

2004

Language:

english

File:

PDF, 169 KB

english, 2004

70

Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: The Losartan Intervention For End point reduction in hypertension (LIFE) study

Michael Hecht Olsen, Kristian Wachtell, Gareth Beevers, Björn Dahlöf, Richard B. Devereux, Ulf de Faire, Frej Fyhrquist, Hans Ibsen, Sverre E. Kjeldsen, Ole Lederballe-Pedersen, Lars H. Lindholm, Pune

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 314 KB

english, 2009

71

The effect of baseline physical activity on cardiovascular outcomes in patients treated for hypertension with LVH.

Eigil Fossum, Gilbert Gleim, Sverre E. Kjeldsen, Stevo Julius, Richard B. Devereux, William E. Brady, Björn Dahlöf

Journal:

American Journal of Hypertension

Year:

2004

Language:

english

File:

PDF, 37 KB

english, 2004

72

Association of left bundle branch block with cardiovascular morbidity and mortality in hypertensive patients with left ventricle hypertrophy: the life study

Zhibin Li, Richard B. Devereux, Sverre E. Kjeldsen, Stevo Julius, Kristian Wachtell, Hans Ibsen, Markku S. Nieminen, Sverker Jern, Peter M. Okin, Bjorn Dahlof

Journal:

American Journal of Hypertension

Year:

2004

Language:

english

File:

PDF, 37 KB

english, 2004

73

Ethnicity, left ventricular hypertrophy regression and cardiovascular events in the life echocardiography substudy

Richard B. Devereux, Kristian Wachtell, Eva Gerdts, Jackson Wright, Markku S. Nieminen, Vasilios Papademetriou, Jonathan M. Edelman, Kurt Boman, Bjorn Dahlof, Katherine E. Harris, Stevo Julius

Journal:

American Journal of Hypertension

Year:

2004

Language:

english

File:

PDF, 47 KB

english, 2004

74

Picxel: perindopril/indapamide has a greater benefit on left ventricular hypertrophy than enalapril

Björn Dahlöf, Philippe Gosse, Pascal Guéret, Olivier Dubourg, Youri Karpov, Giovanni de Simone, Roland Schmieder

Journal:

American Journal of Hypertension

Year:

2004

Language:

english

File:

PDF, 37 KB

english, 2004

75

Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: the life study

Henrik M. Reims, Sverre E. Kjeldsen, Richard B. Devereux, Suzanne Oparil, Stevo Julius, William E. Brady, Björn Dahlöf

Journal:

American Journal of Hypertension

Year:

2004

Language:

english

File:

PDF, 44 KB

english, 2004

76

Extending the benefits of combination antihypertensive therapy to morbidity and mortality reduction

Journal:

American Journal of Hypertension

Year:

2004

Language:

english

File:

PDF, 31 KB

english, 2004

77

Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: The first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension

Kenneth A. Jamerson, George L. Bakris, Chuan-Chuan Wun, Björn Dahlöf, Martin Lefkowitz, Sheryl Manfreda, Bertram Pitt, Eric J. Velazquez, Michael A. Weber

Journal:

American Journal of Hypertension

Year:

2004

Language:

english

File:

PDF, 147 KB

english, 2004

78

Felodipine–Metoprolol Combination Tablet: Maintained Health-Related Quality of Life in the Presence of Substantial Blood Pressure Reduction

Björn Dahlöf, Alessio Degl’ Innocenti, Dag Elmfeldt, Juan Garcia Puig, Torstein Gundersen, James Hosie, Wlodzimierz Januszewicz, Carl-Johan Lindström, Dieter Magometschnigg, Paul Tanser, Pavles Toutou

Journal:

American Journal of Hypertension

Year:

2005

Language:

english

File:

PDF, 132 KB

english, 2005

79

Aortic Valve Sclerosis and Albuminuria Predict Cardiovascular Events Independently in Hypertension: A Losartan Intervention for Endpoint-reduction in Hypertension (LIFE) Substudy

Michael H. Olsen, Kristian Wachtell, Jonathan N. Bella, Vittorio Palmieri, Eva Gerdts, Gunnar Smith, Markku S. Nieminen, Björn Dahlöf, Hans Ibsen, Richard B. Devereux

Journal:

American Journal of Hypertension

Year:

2005

Language:

english

File:

PDF, 211 KB

english, 2005

80

Electrocardiographic and Echocardiographic Detection of Myocardial Infarction in Patients with Left-Ventricular Hypertrophy: The LIFE Study

Silvana Cicala, Richard B. Devereux, Giovanni de Simone, Kristian Wachtell, Eva Gerdts, Kurt Boman, Markku S. Nieminen, Vasilios Papademetriou, Björn Dahlöf, Peter M. Okin

Journal:

American Journal of Hypertension

Year:

2007

Language:

english

File:

PDF, 94 KB

english, 2007

81

Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

Lennart Hansson, Thomas Hedner, Per Lund-Johansen, Sverre Erik Kjeldsen, Lars H Lindholm, Jan Otto Syvertsen, Jan Lanke, Ulf de Faire, Björn Dahlöf, Bengt E Karlberg

Journal:

Year:

2000

Language:

english

File:

PDF, 107 KB

english, 2000

82

Losartan for cardiovascular disease in patients with and without diabetes in the LIFE study

Lars H Lindholm, Björn Dahlöf

Journal:

Year:

2002

Language:

english

File:

PDF, 72 KB

english, 2002

83

Losartan for cardiovascular disease in patients with and without diabetes in the LIFE study

Björn Dahlöf, Lars H Lindholm

Journal:

Year:

2002

Language:

english

File:

PDF, 54 KB

english, 2002

84

Was the LIFE trial independent?

Journal:

Year:

2002

Language:

english

File:

PDF, 45 KB

english, 2002

85

Response from Merck

Journal:

Year:

2003

Language:

english

File:

PDF, 60 KB

english, 2003

86

Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study

Lars H Lindholm, Björn Dahlöf, Jonathan M Edelman, Hans Ibsen, Knut Borch-Johnsen, Michael Hecht Olsen, Steven Snapinn, Kristian Wachtell

Journal:

Year:

2003

Language:

english

File:

PDF, 130 KB

english, 2003

87

Diuretics in the LIFE study

Björn Dahlöf, Richard B Devereux, Sverre E Kjeldsen

Journal:

Year:

2004

Language:

english

File:

PDF, 94 KB

english, 2004

88

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

Neil R Poulter, Hans Wedel, Björn Dahlöf, Peter S Sever, D Gareth Beevers, Mark Caulfield, Sverre E Kjeldsen, Arni Kristinsson, Gordon T McInnes, Jesper Mehlsen, Markku Nieminen, Eoin O'Brien, Jan Öst

Journal:

Year:

2005

Language:

english

File:

PDF, 94 KB

english, 2005

89

ASCOT-BPLA - Authors' reply

Björn Dahlöf, Peter Sever, Neil Poulter, Hans Wedel

Journal:

Year:

2006

Language:

english

File:

PDF, 67 KB

english, 2006

90

Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study

Seibu Mochizuki, Björn Dahlöf, Mitsuyuki Shimizu, Katsunori Ikewaki, Makoto Yoshikawa, Ikuo Taniguchi, Makoto Ohta, Taku Yamada, Kazuhiko Ogawa, Kiyoshi Kanae, Makoto Kawai, Shingo Seki, Fumiko Okazak

Journal:

Year:

2007

Language:

english

File:

PDF, 198 KB

english, 2007

91

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

George L Bakris, Pantelis A Sarafidis, Matthew R Weir, Björn Dahlöf, Bertram Pitt, Kenneth Jamerson, Eric J Velazquez, Linda Staikos-Byrne, Roxzana Y Kelly, Victor Shi, Yann-Tong Chiang, Michael A Web

Journal:

Year:

2010

Language:

english

File:

PDF, 205 KB

english, 2010

92

Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study

Sverre E Kjeldsen, Björn Dahlöf, Richard B Devereux, Stevo Julius, Ulf de Faire, Frej Fyhrquist, Hans Ibsen, Krister Kristianson, Ole Lederballe-Pedersen, Lars H Lindholm, Markku S Nieminen, Per Omvik

Journal:

American Journal of Hypertension

Year:

2000

Language:

english

File:

PDF, 321 KB

english, 2000

93

Left ventricular hypertrophy and angiotensin II antagonists

Journal:

American Journal of Hypertension

Year:

2001

Language:

english

File:

PDF, 195 KB

english, 2001

94

Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertropy in hypertensive patients: the LIFE study

Peter M Okin, Richard B Devereux, Sverker Jern, Stevo Julius, Sverre E Kjeldsen, Björn Dahlöf

Journal:

American Journal of Hypertension

Year:

2001

Language:

english

File:

PDF, 135 KB

english, 2001

95

Predictors of cardiovascular events in 9,194 hypertensive patients with left ventricular hypertrophy. The LIFE study

Sverre E. Kjeldsen, Björn Dahlőf, Richard B. Devereux, Stevo Julius, Ulf de Faire, Frej Fyhrquist, Hans Ibsen, Krister Kristianson, Ole Lederballe-Pedersen, Lars H. Lindholm, Markku S. Nieminen, Per O

Journal:

American Journal of Hypertension

Year:

2001

Language:

english

File:

PDF, 38 KB

english, 2001

96

Similar effects of isolated systolic and combined hypertension on left ventricular geometry and function: the LIFE study

Vasilios Papademetriou, Richard B Devereux, Puneet Narayan, Kristian Wachtell, Jonathan N Bella, Eva Gerdts, Steven G Chrysant, Björn Dahlöf

Journal:

American Journal of Hypertension

Year:

2001

Language:

english

File:

PDF, 99 KB

english, 2001

97

Pulse pressure and cardiovascular risk factors in patients with hypertension and ECG LVH: the life study

Vasilios Papademetriou, Richard B. Devereux, Kristian Wachtell, Vittorio Palmieri, Peter Kokkinos, Bjorn Dahlof

Journal:

American Journal of Hypertension

Year:

2001

Language:

english

File:

PDF, 38 KB

english, 2001

98

Regression of hypertensive left ventricular hypertrophy by angiotensin receptor blockade versus beta-blockade: the LIFE trial

Richard B. Devereux, Eva Gerdts, Kristian Wachtell, Kurt Boman, Markku S. Nieminen, Vasilios Papademetriou, Bjorn Dahlof

Journal:

American Journal of Hypertension

Year:

2002

Language:

english

File:

PDF, 33 KB

english, 2002

99

Does losartan treated patients with albuminuria have better cardiovascular outcome than those treated with atenolol? The LIFE study

Kristian Wachtell, Michael H. Olsen, Björn Dahlöf, Richard B. Devereux, Sverre Kjeldsen, Markku S. Nieminen, Peter M. Okin, Knut Borch-Johnsen, Hans Ibsen

Journal:

American Journal of Hypertension

Year:

2002

Language:

english

File:

PDF, 38 KB

english, 2002

100

Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT): blood pressure changes at 2.5 years of follow-up

Peter S. Sever, Bjorn Dahlof, Neil R. Poulter, Hans Wedel

Journal:

American Journal of Hypertension

Year:

2002

Language:

english

File:

PDF, 60 KB

english, 2002